February 22, 2021August 24, 2022
Enhertu Approved in UK for Inoperable, Advanced Breast Cancer
News
Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the U.K. for the treatment of adults with inoperable or metastatic ... Read more
February 18, 2021February 18, 2021
Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC
News
An open-label Phase 2 clinical trial will test the safety and efficacy of IRX-2, an experimental immunology-based cancer therapy, in ... Read more
February 15, 2021February 15, 2021
Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer
News
Seagen’s Tukysa (tucatinib) has been approved by the European Commission (EC) as part of a triple-combination therapy for people with previously ... Read more
February 11, 2021February 11, 2021
Trial Testing AL101 in TNBC Doses First Patient
News
The first participant has been dosed in the Phase 2 clinical trial TENACITY, which is evaluating Ayala Pharmaceuticals‘ investigational therapy ... Read more
February 8, 2021February 8, 2021
‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer
News
After promising results from patients enrolled to date, Atossa Therapeutics halted an Australian Phase 2 clinical trial evaluating its investigative ... Read more
February 4, 2021February 4, 2021
Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors
News
Theralink Technologies announced that it has begun testing its new profiling biomarker assay — a test that could potentially provide ... Read more
February 1, 2021February 1, 2021
US Study Enrolling Women to Help Determine Best Screening Practices
News
A national study is seeking women in the U.S. to help determine the safest and best way to screen for ... Read more
January 28, 2021January 28, 2021
Nonprofit Highlights Importance of Global Teamwork for World Cancer Day
News
In honor of World Cancer Day on Feb. 4, the Breast International Group (BIG) emphasized the importance of wide-scale cooperation ... Read more
January 25, 2021January 25, 2021
Enhertu Approved in EU for Inoperable, Advanced Breast Cancer
News
The European Commission has conditionally approved Enhertu (trastuzumab deruxtecan) for adults in the EU with inoperable or metastatic HER2-positive breast cancer ... Read more
January 21, 2021January 21, 2021
Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA
News
Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and ... Read more
January 18, 2021January 18, 2021
Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors
News
Mindfulness can significantly improve brain health and pain perception in breast cancer survivors, according to a small Canadian study. The ... Read more
January 14, 2021January 14, 2021
Genetic Test for Advanced Breast Cancer Launched in EU
News
Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic ... Read more

April 9, 2020April 9, 2020

Positive Results Support Early Halt to Phase 3 Trial Testing Sacituzumab Govitecan for TNBC

News

Immunomedics has halted its Phase 3 confirmatory trial of sacituzumab govitecan, due to strong evidence of its ability to delay disease progression in patients with advanced triple-negative breast cancer (TNBC). ... Read more

April 2, 2020April 2, 2020

CytoDyn Seeks Preliminary FDA Meeting on Leronlimab’s Breakthrough Therapy Status

News

After a recommendation from the U.S. Food and Drug Administration (FDA), CytoDyn is planning to ask the regulatory agency for a preliminary meeting to discuss the granting of breakthrough therapy status ... Read more

March 26, 2020March 26, 2020

Tumor Suppressor Neurofibromin Interacts with Estrogen Receptor, Revealing Potential Combo Breast Cancer Therapy

News

A tumor suppressor protein called neurofibromin, known to block the cancer-inducing Ras pathway, also was found to interact directly with the estrogen receptor (ER) with mutations in this protein leading ... Read more

March 23, 2020March 23, 2020

Komen Suggests Delaying Routine Mammograms During COVID-19 Outbreak

News

To help minimize the threat of COVID-19 to themselves and others, healthy women at average risk should postpone breast cancer screening until later this year, Susan G. Komen recommends. However, ... Read more

March 20, 2020March 20, 2020

Herzuma, Biosimilar to Herceptin, Available in US for HER2-positive Breast Cancers

News

Herzuma, a biosimilar to Genentech‘s Herceptin (trastuzumab), is now available in the U.S. for the same indications as the reference therapy, including for the treatment of HER2-positive breast cancers and stomach cancers. The ... Read more

March 18, 2020March 18, 2020

Fewer False-positive Mammograms May Need Human-Computer Mix

News

Artificial intelligence (AI) could be combined with radiologist assessments to improve the accuracy of breast cancer screenings, a study suggests. The study, “Evaluation of Combined Artificial Intelligence and Radiologist Assessment ... Read more

March 16, 2020March 23, 2020

Tumor Mutations May Help Predict Patients Best Suited to Pre-surgery Chemotherapy

News

Researchers identified mutations in breast cancer samples that may help predict which patients have the best chances of success from pre-surgical, or neoadjuvant, chemotherapy, and which may need an alternative ... Read more

March 13, 2020March 13, 2020

Platinum Chemo No Better than Standard in BRCA-mutated Early BC, Trial Finds

News

Women with newly diagnosed breast cancer who carry a mutation in their BRCA genes may continue to receive the standard pre-surgery chemotherapy regimen used for other breast cancer patients, according ... Read more

March 11, 2020March 11, 2020

Certain Inhaled Anesthetics May Promote Breast Cancer Spread, Mouse Study Suggests

News

The use of certain inhaled anesthetics during breast cancer surgery may increase the risk of cancer spreading in the body, a new study done in mice suggests. The study, “Distinct ... Read more

March 9, 2020March 9, 2020

Lesser-known DNA Repair Process May Be Therapeutic Target in Certain Breast Cancers, Study Says

News

Some breast cancers with mutations in DNA damage repair genes may rely on a DNA repair enzyme called polymerase theta for survival, a new study shows, suggesting that blocking this enzyme ... Read more

March 6, 2020March 6, 2020

Breast Cancer Cells Precisely Mapped; Study Notes Potential for Individualized Treatment

News

Researchers have mapped, at the single-cell level, the diverse types and arrangements of cells within breast cancer tumors, revealing how genetic changes shape the complex tumor landscape. The findings could ... Read more

March 5, 2020March 5, 2020

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

News

In recognition of Rare Disease Day Feb. 29, BioNews Services launched a social media campaign last month asking patients to describe what makes them rare. Running Feb. 7–29, the #WhatMakesMeRare ... Read more

Enhertu Approved in UK for Inoperable, Advanced Breast Cancer

Phase 2 Trial Will Test IRX-2 Combined With Keytruda, Chemotherapy for TNBC

Tukysa Combo Approved in EU for Advanced HER2-Positive Breast Cancer

Trial Testing AL101 in TNBC Doses First Patient

‘Overwhelmingly Positive’ Data Halts Endoxifen Phase 2 Trial for Invasive Cancer

Theralink Begins Testing New Biomarker Assay for Breast Cancer Tumors

US Study Enrolling Women to Help Determine Best Screening Practices

Nonprofit Highlights Importance of Global Teamwork for World Cancer Day

Enhertu Approved in EU for Inoperable, Advanced Breast Cancer

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors

Genetic Test for Advanced Breast Cancer Launched in EU